Precision BioLogic

Precision BioLogic Inc. is a clinical laboratory diagnostics manufacturer specializing in frozen hemostasis reagents, controls, and specialty plasmas for coagulation and thrombophilia testing. The company produces a comprehensive portfolio of diagnostic products including: quality control plasmas (normal, abnormal, and reference controls), factor-deficient plasmas (Factors II through XII), specialty reagents for lupus anticoagulant detection, and diagnostic kits for factor assays and hemophilia testing. Key products include Chromogenic Factor VIII (bovine formulation, FDA-cleared), Chromogenic Factor IX, Hex LA, LA Check, LA Sure, and custom solutions. The company serves clinical hemostasis laboratories, hematology departments, and thrombosis centers globally. Products are supplied in frozen format, ready-to-use format eliminating reconstitution errors. The company maintains ISO 13485 certification and FDA clearance for select products. Precision BioLogic operates a customer portal for lot-specific quality control and assay certificates. The firm also publishes scientific literature and operates the Fritsma Factor educational resource for hemostasis professionals. Recent acquisition of George King Bio-Medical (October 2025) and achievement of IVDR compliance (December 2025) reflect ongoing product expansion and regulatory readiness.